共 25 条
- [21] Two-Year Clinical Outcome With Drug-Eluting Stents Versus Bare-Metal Stents in a Real-World Registry of Unprotected Left Main Coronary Artery Stenosis from the Italian Society of Invasive Cardiology AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (11): : 1463 - 1468
- [23] Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions) JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1178 - 1187
- [24] Impact of Sex on 3-Year Outcome After Percutaneous Coronary Intervention Using Bare-Metal and Drug-Eluting Stents in Previously Untreated Coronary Artery Disease Insights From the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (07) : 603 - 610
- [25] Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (20) : 1925 - 1934